Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)
-
- STATUS
- Recruiting
Summary
Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)
Description
A Multicenter, Open-Label Evaluation of Treatment Satisfaction, Tolerability, Safety, and Preference of Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated with Triptans
Patient Inclusion Criteria:
- Men or Women 18 to 65 years of age
- Have a history of 2 to 6 migraine headaches (on average) per month
- Suffering from Migraines for more than one (1) year before first office visit
- Willing to stop or discontinue current treatment for Migraines Headaches
- Diagnosis of Migraine Headaches before the age of 50
- Be Fluent in English
Patient Exclusion Criteria:
- Can not read or understand English Forms
- History of Epilepsy or Seizure or any other Neurologic Condition
- HIV/AIDS, Cancer or Hepatitis C (detectable or undetectable)
- Hemiplegic or Basilar Migraines
- Terminal Illnesses
- Uncontrolled Cardiovascular Diseases (Uncontrolled Hypertension)
- Minors (under the legal age of 18)
- Older than the permitted age of 65
Details
| Condition | Migraine and Cluster Headaches |
|---|---|
| Clinical Study Identifier | TX134653 |
| Last Modified on | 8 November 2020 |
Eligibility
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer